Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma
Vera Mattijssen(Radboud University Nijmegen), Paul van den Broek(Leiden University), D. J. Ruiter(Radboud University Nijmegen), F.B.M. Joosten, H. Bier(Eppendorf (Germany)), Alexander de Graeff(Oncode Institute), P. Hupperets(Maastricht University Medical Centre), P H de Mulder(European Organisation for Research and Treatment of Cancer), Peter Palmer(Springhouse)
Cited by 30
Related Papers
The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care
|European Journal of Cancer|2005|687
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
|JNCI Journal of the National Cancer Institute|2009|282
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
|Molecular and Cellular Biology|1989|280
Aneurysmal bone cysts.A clinicopathological study of 105 cases
|Cancer|1977|269